Certain Shares of ExpreS2ion Biotech Holding AB are subject to a Lock-Up Agreement Ending on 4-AUG-2022.
Details:
All members of the Company's board of directors and senior management with shareholdings in the company have undertaken towards Vator Securities AB, subject to customary exceptions, not to sell or otherwise transfer their shares without first, in each separate case, ascertain a written approval from Vator Securities AB. The lock-up period lasts for a period of 90 days following the publication of the outcome of the Rights Issue.